IL-27 induces CD4+ T cell-derived IL-10, which is canonical disease-enhancer in leishmaniasis, whilst at the same time it suppresses Th17/IL-17 [82], both of which can promote disease progression when present. Here, IL10 is linked to leishmaniasis.